Ciforadenant (CPI-444) (C007B-101990)

InformationCiforadenant (CPI-444) Ciforadenant (CPI-444, V81444) is a potent and selective Adenosine A2A receptor antagonist. It binds to A2A receptors with a Ki of 3.54 nmol/L and demonstrates a greater than 50-fold selectivity for the A2A receptor over other adenosine receptor subtypes.TargetsA2AR 3.54 nM(Ki)In vitroCPI-444 restores T-cell activation in vitro.In vivoCPI-444 treatment resulted in a similar inhibition of tumor growth in the B16F10 melanoma (100 mg/kg) and RENCA renal cell cancer syngeneic models (10 mg/kg). It enhances T-cell activation in both the periphery and tumor microenvironment.

Specifications and Purity: ≥99%

Molecular Formula: C20H21N7O3

Molecular Weight: 407.43

PubChem CID: 44537963

Isomeric SMILES: CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)CO[C@H]5CCOC5

Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/C413566-SCI_a3ca0e3039243e5e4e98cadece9341f2.pdf